Literature DB >> 17451800

Treatment of airway inflammation improves exercise pulmonary gas exchange and performance in asthmatic subjects.

Hans C Haverkamp1, Jerome A Dempsey, David F Pegelow, Jordan D Miller, Lee M Romer, Marcus Santana, Marlowe W Eldridge.   

Abstract

BACKGROUND: Asthma is an inflammatory disease of the airways that can lead to impaired arterial blood oxygenation during exercise.
OBJECTIVE: We asked whether treatment of airway inflammation in asthmatic subjects would improve arterial blood gases during whole-body exercise.
METHODS: By using a double-blind parallel-group design, 19 asthmatic subjects completed treadmill exercise to exhaustion on 2 occasions: (1) before and (2) after 6 weeks' treatment with an inhaled corticosteroid (ICS; n = 9) or placebo (n = 10).
RESULTS: The ICS group had improved resting pulmonary function, decreased exercise-induced bronchospasm, and decreased postexercise sputum histamine during the posttreatment study compared with that during the pretreatment study. In the ICS group exercise Pao(2) was significantly increased after treatment (84.8 to 93.8 mm Hg). Increased alveolar ventilation (arterial Pco(2) decreased from 36.9 to 34.1 mm Hg) accounted for 37% of the increased Pao(2) and improved gas exchange efficiency (alveolar-to-arterial Po(2) difference decreased from 22.5 to 16.3 mm Hg) accounted for the remaining 63% of the increased Pao(2) after treatment. In the ICS group exercise time to exhaustion was increased from 9.9 minutes during the pretreatment study to 14.8 minutes during the posttreatment study.
CONCLUSION: Treatment of airway inflammation in asthmatic subjects can improve arterial blood oxygenation during exercise by (1) improving airway function, thereby allowing increased alveolar ventilation during exercise, and (2) improving the efficiency of alveolar-to-arterial blood O(2) exchange. CLINICAL IMPLICATIONS: In asthmatic patients ICSs not only attenuate exercise-induced bronchospasm but also improve arterial blood oxygenation during exercise.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17451800     DOI: 10.1016/j.jaci.2007.03.013

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

Review 1.  Asthma, outdoor air quality and the Olympic Games.

Authors:  Donald C McKenzie; Louis-Philippe Boulet
Journal:  CMAJ       Date:  2008-08-07       Impact factor: 8.262

2.  Is the healthy respiratory system built just right, overbuilt, or underbuilt to meet the demands imposed by exercise?

Authors:  Jerome A Dempsey; Andre La Gerche; James H Hull
Journal:  J Appl Physiol (1985)       Date:  2020-08-13

3.  The Effect of 400 µg Inhaled Salbutamol on 3 km Time Trial Performance in a Low Humidity Environment.

Authors:  John Molphy; John W Dickinson; Neil J Chester; Mike Loosemore; Gregory Whyte
Journal:  J Sports Sci Med       Date:  2017-12-01       Impact factor: 2.988

4.  Acute impact of inhaled short acting b2-agonists on 5 km running performance.

Authors:  John Dickinson; Jiu Hu; Neil Chester; Mike Loosemore; Greg Whyte
Journal:  J Sports Sci Med       Date:  2014-05-01       Impact factor: 2.988

5.  Exercise-induced Bronchodilation Equalizes Exercise Ventilatory Mechanics despite Variable Baseline Airway Function in Asthma.

Authors:  Matthew J Rossman; Greg Petrics; Andrew Klansky; Kasie Craig; Charles G Irvin; Hans Christian Haverkamp
Journal:  Med Sci Sports Exerc       Date:  2022-02-01       Impact factor: 5.411

6.  Exercise-induced asthma: critical analysis of the protective role of montelukast.

Authors:  Terrence W Carver
Journal:  J Asthma Allergy       Date:  2009-10-22

Review 7.  Advances in the Evaluation of Respiratory Pathophysiology during Exercise in Chronic Lung Diseases.

Authors:  Denis E O'Donnell; Amany F Elbehairy; Danilo C Berton; Nicolle J Domnik; J Alberto Neder
Journal:  Front Physiol       Date:  2017-02-22       Impact factor: 4.566

8.  Impact of detecting and treating exercise-induced bronchoconstriction in elite footballers.

Authors:  Anna R Jackson; James H Hull; James G Hopker; John W Dickinson
Journal:  ERJ Open Res       Date:  2018-04-20

9.  The Effects of PCSO-524®, a Patented Marine Oil Lipid derived from the New Zealand Green Lipped Mussel (Perna canaliculus), on Pulmonary and Respiratory Muscle Function in Non-asthmatic Elite Runners.

Authors:  Ren-Jay Shei; Emily M Adamic; Robert F Chapman; Timothy D Mickleborough
Journal:  Int J Exerc Sci       Date:  2018-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.